Your session is about to expire
← Back to Search
Movement-2-Music Exercise Program for Mobility Disabilities (M2M LEADERS Trial)
M2M LEADERS Trial Summary
This trial is testing the effects of an innovative exercise program, movement-2-music (M2M), on health and fitness outcomes in adults with physical/mobility disabilities. One hundred and eight participants will be recruited and randomly enrolled into one of two groups: M2M or waitlist control. The primary aim of this study is to determine the effects of the 12-week M2M program on health and fitness in participants with physical/mobility disabilities. The study will also compare the observed effects of the program to a previous M2M study, and test whether adherence (attendance to the 12-week program) affects the
M2M LEADERS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowM2M LEADERS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.M2M LEADERS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can use my arms and/or legs to exercise and follow directions.You have trouble hearing music, which affects your ability to exercise.You are currently smoking or quit less than 6 months ago.I cannot follow a group exercise class due to poor eyesight.You have taken part in an exercise program or something similar in the past 6 months.You have trouble with memory and thinking.I have been diagnosed with a neurological condition by a doctor.You have any reasons that make it unsafe for you to exercise according to the American College of Sports Medicine guidelines.I have an active pressure ulcer.
- Group 1: eM2M
- Group 2: Waitlist Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this clinical trial open to individuals under the age of fifty?
"Eligibility for this research study is confined to those between 18 and 70 years of age. For patients under the age of 18, there are 384 studies available; however, 2,531 trials exist for individuals over 65."
Is enrollment still open for this research project?
"According to clinicaltrials.gov, the recruitment for this healthcare study is ongoing and has been since August 9th 2019. The data was last reviewed on October 13th 2022."
How many individuals are being administered this therapy in the current experiment?
"Affirmative. Research hosted on clinicaltrials.gov demonstrates that this examination, which was inaugurated on August 9th 2019, is actively recruiting patients. Approximately 108 participants are needed to be recruited from two medical centres."
What purpose is the clinical trial aiming to achieve?
"For the primary outcome assessment of this medical trial, cardiovascular health will be monitored from the start to 12 weeks post-intervention. Secondary objectives include tracking physical activity with a Godin Leisure Time Exercise Questionnaire and gauging lower extremity function using the Timed Up and Go test as well as measuring general wellbeing by means of National Institutes of Health Patient-Reported Outcomes Measurement Information System Global-10 Health Items."
Am I eligible to participate in this clinical trial?
"Applicants with spina bifida, between 18 to 70 years old will be considered for this trial. 108 people are expected to participate in total."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
Most responsive sites:
- UAB Research Collaborative: < 48 hours
- UAB/Lakeshore Research Collaborative: < 48 hours
Share this study with friends
Copy Link
Messenger